Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres











Gamme d'année
1.
Cell Tissue Res ; 379(3): 511-520, 2020 Mar.
Article de Anglais | MEDLINE | ID: mdl-31776824

RÉSUMÉ

Despite being considered present in most vascularised tissues, lymphatic vessels have not been properly shown in human adipose tissue (AT). Our goal in this study is to investigate an unanswered question in AT biology, regarding lymphatic network presence in tissue parenchyma. Using human subcutaneous (S-) and visceral (V-) AT samples with whole mount staining for lymphatic specific markers and three-dimensional imaging, we showed lymphatic capillaries and larger lymphatic vessels in the human VAT. Conversely, in the human SAT, microcirculatory lymphatic vascular structures were rarely detected and no initial lymphatics were found.


Sujet(s)
Tissu adipeux/anatomie et histologie , Vaisseaux lymphatiques/anatomie et histologie , Tissu adipeux/vascularisation , Tissu adipeux/physiologie , Femelle , Humains , Imagerie tridimensionnelle , Immunohistochimie , Graisse intra-abdominale/anatomie et histologie , Graisse intra-abdominale/vascularisation , Graisse intra-abdominale/physiologie , Vaisseaux lymphatiques/vascularisation , Vaisseaux lymphatiques/physiologie , Mâle , Adulte d'âge moyen , Graisse sous-cutanée/anatomie et histologie , Graisse sous-cutanée/vascularisation , Graisse sous-cutanée/physiologie
2.
J Cardiovasc Pharmacol Ther ; 24(6): 559-566, 2019 11.
Article de Anglais | MEDLINE | ID: mdl-31056933

RÉSUMÉ

Statins may precipitate the onset of type 2 diabetes (T2D) in high-risk patients. In contrast, only the subset of individuals with insulin resistance and/or diabetes receives cardiovascular benefits with fibrates. In this context, previous observations from our laboratory suggested that atorvastatin induced an increase in visceral adipose tissue (VAT), whereas fenofibrate had the opposite effects in rabbits. Therefore, we determined the mass, morphology, and vascularization of VAT in New Zealand white rabbits (n = 6/group) that received 0.33 or 2.6 mg/kg/d of atorvastatin or fenofibrate, respectively, during 2 months. As expected, the cholesterol from the atorvastatin group was lower after treatment, while triglycerides decreased in the fenofibrate group. The mass of VAT from the fenofibrate group was 46% lower compared to the controls, meanwhile atorvastatin was associated with a larger diameter of adipocytes (+65%) than that of the control and fenofibrate groups. Fibroblast growth factor 2 (FGF2) gene expression was lower in the fenofibrate group than in the control group (-54%). By contrast, vascular endothelial growth factor A (VEGF-A) gene expression in fenofibrate-treated rabbits was 110% higher than in the control group. In agreement with the gene expression, the marker of angiogenesis platelet endothelial cell adhesion molecule 1 was slightly but significantly higher (+10%) in rabbits treated with fenofibrate than in controls, as determined by immunohistochemistry. These results suggest that fenofibrate is associated with a favorable remodeling of VAT, that is, reduced mass and increased vascularization in normolipemic rabbits; in contrast, atorvastatin induced a nonfavorable remodeling of VAT. These results may be related to the cardiovascular benefits of fenofibrate and the increased risk of T2D in high-risk patients induced by atorvastatin.


Sujet(s)
Adipocytes/effets des médicaments et des substances chimiques , Adiposité/effets des médicaments et des substances chimiques , Atorvastatine/pharmacologie , Fénofibrate/pharmacologie , Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/pharmacologie , Hypolipémiants/pharmacologie , Graisse intra-abdominale/vascularisation , Graisse intra-abdominale/effets des médicaments et des substances chimiques , Néovascularisation physiologique/effets des médicaments et des substances chimiques , Adipocytes/métabolisme , Animaux , Cholestérol/sang , Facteur de croissance fibroblastique de type 2/génétique , Facteur de croissance fibroblastique de type 2/métabolisme , Graisse intra-abdominale/métabolisme , Mâle , Antigènes CD31/génétique , Antigènes CD31/métabolisme , Lapins , Transduction du signal , Triglycéride/sang , Facteur de croissance endothéliale vasculaire de type A/génétique , Facteur de croissance endothéliale vasculaire de type A/métabolisme
3.
Clinics (Sao Paulo) ; 71(9): 528-36, 2016 Sep.
Article de Anglais | MEDLINE | ID: mdl-27652835

RÉSUMÉ

OBJECTIVE: The purpose of this study was to investigate the effects of resistance training on angiogenesis markers of visceral adipose tissue in ovariectomized rats. METHOD: Adult Sprague-Dawley female rats were divided into four groups (n=6 per group): sham-sedentary, ovariectomized sedentary, sham-resistance training and ovariectomized resistance training. The rats were allowed to climb a 1.1-m vertical ladder with weights attached to their tails and the weights were progressively increased. Sessions were performed three times per week for 10 weeks. Visceral adipose tissue angiogenesis and morphology were analyzed by histology. VEGF-A mRNA and protein levels were analyzed by real-time PCR and ELISA, respectively. RESULTS: Ovariectomy resulted in higher body mass (p=0.0003), adipocyte hypertrophy (p=0.0003), decreased VEGF-A mRNA (p=0.0004) and protein levels (p=0.0009), and decreased micro-vascular density (p=0.0181) in the visceral adipose tissue of the rats. Resistance training for 10 weeks was not able to attenuate the reduced angiogenesis in the visceral adipose tissue of the ovariectomized rats. CONCLUSION: Our findings indicate that the resistance training program used in this study could not ameliorate low angiogenesis in the visceral adipose tissue of ovariectomized rats.


Sujet(s)
Oestrogènes/déficit , Graisse intra-abdominale/vascularisation , Néovascularisation physiologique/physiologie , Ovariectomie/méthodes , Conditionnement physique d'animal/physiologie , Entraînement en résistance/méthodes , Adipocytes/physiologie , Animaux , Marqueurs biologiques/analyse , Test ELISA , Femelle , Immunohistochimie , Graisse intra-abdominale/métabolisme , Répartition aléatoire , Rat Sprague-Dawley , Réaction de polymérisation en chaine en temps réel , Reproductibilité des résultats , Protéines ribosomiques/analyse , Facteurs temps , Facteur de croissance endothéliale vasculaire de type A/analyse , Récepteur-2 au facteur croissance endothéliale vasculaire/analyse
4.
Clinics ; Clinics;71(9): 528-536, Sept. 2016. tab, graf
Article de Anglais | LILACS | ID: lil-794640

RÉSUMÉ

OBJECTIVE: The purpose of this study was to investigate the effects of resistance training on angiogenesis markers of visceral adipose tissue in ovariectomized rats. METHOD: Adult Sprague-Dawley female rats were divided into four groups (n=6 per group): sham-sedentary, ovariectomized sedentary, sham-resistance training and ovariectomized resistance training. The rats were allowed to climb a 1.1-m vertical ladder with weights attached to their tails and the weights were progressively increased. Sessions were performed three times per week for 10 weeks. Visceral adipose tissue angiogenesis and morphology were analyzed by histology. VEGF-A mRNA and protein levels were analyzed by real-time PCR and ELISA, respectively. RESULTS: Ovariectomy resulted in higher body mass (p=0.0003), adipocyte hypertrophy (p=0.0003), decreased VEGF-A mRNA (p=0.0004) and protein levels (p=0.0009), and decreased micro-vascular density (p=0.0181) in the visceral adipose tissue of the rats. Resistance training for 10 weeks was not able to attenuate the reduced angiogenesis in the visceral adipose tissue of the ovariectomized rats. CONCLUSION: Our findings indicate that the resistance training program used in this study could not ameliorate low angiogenesis in the visceral adipose tissue of ovariectomized rats.


Sujet(s)
Animaux , Femelle , Conditionnement physique d'animal/physiologie , Ovariectomie/méthodes , Néovascularisation physiologique/physiologie , Graisse intra-abdominale/vascularisation , Oestrogènes/déficit , Entraînement en résistance/méthodes , Protéines ribosomiques/analyse , Facteurs temps , Test ELISA , Immunohistochimie , Marqueurs biologiques/analyse , Répartition aléatoire , Reproductibilité des résultats , Rat Sprague-Dawley , Adipocytes/physiologie , Récepteur-2 au facteur croissance endothéliale vasculaire/analyse , Facteur de croissance endothéliale vasculaire de type A/analyse , Graisse intra-abdominale/métabolisme , Réaction de polymérisation en chaine en temps réel
5.
Br J Nutr ; 107(1): 36-44, 2012 Jan.
Article de Anglais | MEDLINE | ID: mdl-21736766

RÉSUMÉ

Several metabolic disturbances during obesity are associated with adipose tissue-altered functions. Adipocytes contain the renin-angiotensin system (RAS), which regulates signalling pathways that control angiogenesis via Akt in an autocrine fashion. Soya protein (Soy) consumption modifies the gene expression pattern in adipose tissue, resulting in an improved adipocyte function. Therefore, the aim of the present work is to study whether dietary Soy regulates the expression of RAS and angiogenesis-related genes and its association with the phosphorylated state of Akt in the adipose tissue of obese rats. Animals were fed a 30 % Soy or casein (Cas) diet containing 5 or 25 % fat for 160 d. mRNA abundance was studied in the adipose tissue, and Akt phosphorylation and hormone release were measured in the primary adipocyte culture. The present results show that Soy treatment in comparison with Cas consumption induces lower angiotensin release and increased insulin-stimulated Akt activation in adipocytes. Furthermore, Soy consumption varies the expression of RAS and angiogenesis-related genes, which maintain cell size and vascularity in the adipose tissue of rats fed a high-fat diet. Thus, adipocyte hypertrophy and impaired angiogenesis, which are frequently observed in dysfunctional adipose tissue, were avoided by consuming dietary Soy. Taken together, these findings suggest that Soy can be used as a dietary strategy to preserve adipocyte functionality and to prevent obesity abnormalities.


Sujet(s)
Graisse intra-abdominale/métabolisme , Obésité/diétothérapie , Obésité/métabolisme , Protéines de légume/usage thérapeutique , Système rénine-angiotensine , Protéines de soja/usage thérapeutique , Angiotensines/métabolisme , Animaux , Cellules cultivées , Matières grasses alimentaires/effets indésirables , Régulation de l'expression des gènes , Hypertrophie/prévention et contrôle , Insuline/sang , Insuline/métabolisme , Graisse intra-abdominale/vascularisation , Graisse intra-abdominale/anatomopathologie , Mâle , Néovascularisation pathologique/prévention et contrôle , Obésité/sang , Obésité/anatomopathologie , Phosphorylation , Maturation post-traductionnelle des protéines , Protéines proto-oncogènes c-akt/métabolisme , ARN messager/métabolisme , Rats , Rat Sprague-Dawley
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE